{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:01:36Z","timestamp":1761310896471,"version":"3.40.5"},"reference-count":214,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.mam.2013.10.004","type":"journal-article","created":{"date-parts":[[2013,10,26]],"date-time":"2013-10-26T07:46:19Z","timestamp":1382773579000},"page":"15-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Role of genetics in diagnosis and therapy of acquired liver disease"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6298-4717","authenticated-orcid":false,"given":"Vincent","family":"Zimmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Lammert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0005","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical, practice guidelines: management of cholestatic liver diseases","volume":"51","author":"EASL","year":"2009","journal-title":"J. Hepatol."},{"issue":"7422","key":"10.1016\/j.mam.2013.10.004_b0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An integrated map of genetic variation from 1092 human genomes","volume":"491","author":"Abecasis","year":"2012","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.mam.2013.10.004_b0015","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ejim.2006.04.012","article-title":"Are plasma lipid levels related to ABCG5\/ABCG8 polymorphisms? A preliminary study in siblings with gallstones","volume":"17","author":"Acalovschi","year":"2006","journal-title":"Eur. J. Intern. Med."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0020","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/hep.23690","article-title":"Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin","volume":"52","author":"Akuta","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0025","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/clpt.2012.107","article-title":"Predictive genetic testing for drug-induced liver injury: considerations of clinical utility","volume":"92","author":"Alfirevic","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.mam.2013.10.004_b0030","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/hep.21424","article-title":"Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry","volume":"44","author":"Andrade","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2893.2012.01621.x","article-title":"IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4","volume":"20","author":"Antaki","year":"2013","journal-title":"J. Viral Hepat."},{"issue":"5","key":"10.1016\/j.mam.2013.10.004_b0040","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00228-012-1429-9","article-title":"NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy","volume":"69","author":"Azuma","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.mam.2013.10.004_b0045","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1053\/j.gastro.2010.10.004","article-title":"IL28B and the control of hepatitis C virus infection","volume":"139","author":"Balagopal","year":"2010","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0050","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1194\/jlr.M011205","article-title":"Pnpla3\/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome","volume":"52","author":"Basantani","year":"2011","journal-title":"J. Lipid Res."},{"issue":"36","key":"10.1016\/j.mam.2013.10.004_b0055","doi-asserted-by":"crossref","first-page":"33336","DOI":"10.1074\/jbc.M105193200","article-title":"Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage","volume":"276","author":"Baulande","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0060","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.gastro.2011.09.039","article-title":"Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection","volume":"142","author":"Beinhardt","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1194\/jlr.M500215-JLR200","article-title":"Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriers","volume":"47","author":"Bergheim","year":"2006","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/j.mam.2013.10.004_b0070","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","article-title":"Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis","volume":"6","author":"Bergquist","year":"2008","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0075","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO(3)(\u2212) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0080","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jhep.2008.10.021","article-title":"The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice","volume":"50","author":"Bjornsson","year":"2009","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0085","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers in severe drug-induced liver disease","volume":"42","author":"Bjornsson","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.mam.2013.10.004_b0090","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jhep.2011.01.050","article-title":"IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C","volume":"55","author":"Bochud","year":"2011","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.mam.2013.10.004_b0095","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.cell.2010.05.034","article-title":"Whole-genome sequencing breaks the cost barrier","volume":"141","author":"Bonetta","year":"2010","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.mam.2013.10.004_b0100","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.mam.2013.10.004_b0105","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/ng2101","article-title":"A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease","volume":"39","author":"Buch","year":"2007","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.mam.2013.10.004_b0110","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1053\/j.gastro.2010.09.003","article-title":"Loci from a genome-wide analysis of bilirubin levels are associated with gallstone risk and composition","volume":"139","author":"Buch","year":"2010","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.mam.2013.10.004_b0115","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.dld.2012.05.006","article-title":"PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals","volume":"44","author":"Burza","year":"2012","journal-title":"Dig. Liver Dis."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0120","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2010.12.020","article-title":"Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis","volume":"55","author":"Cai","year":"2011","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.mam.2013.10.004_b0125","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the study of liver diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0130","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0135","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/hep.23812","article-title":"Patatin-like phospholipase domain-containing 3\/adiponutrin deficiency in mice is not associated with fatty liver disease","volume":"52","author":"Chen","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0140","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1053\/j.gastro.2011.12.057","article-title":"Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis C","volume":"142","author":"Chu","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ajg.2010.370","article-title":"IL28B genomic-based treatment paradigms for patients with chronic hepatitis C infection: the future of personalized HCV therapies","volume":"106","author":"Clark","year":"2011","journal-title":"Am. J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.mam.2013.10.004_b0150","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s10620-012-2171-y","article-title":"The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection","volume":"57","author":"Clark","year":"2012","journal-title":"Dig. Dis. Sci."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0155","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2006.06.008","article-title":"Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1","volume":"131","author":"Conjeevaram","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.mam.2013.10.004_b0160","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/hep.24244","article-title":"Patatin-like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma","volume":"53","author":"Corradini","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0165","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.gastro.2006.11.023","article-title":"Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes","volume":"132","author":"Daly","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0170","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/03602532.2011.605790","article-title":"Genetic association studies in drug-induced liver injury","volume":"44","author":"Daly","year":"2012","journal-title":"Drug Metab. Rev."},{"issue":"7","key":"10.1016\/j.mam.2013.10.004_b0175","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B\u22175701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0180","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jhep.2012.03.020","article-title":"Immediate vs. delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: a model-based analysis","volume":"57","author":"Deuffic-Burban","year":"2012","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0185","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/gut.2008.159541","article-title":"Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy","volume":"58","author":"Dixon","year":"2009","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0190","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/hep.21316","article-title":"HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study","volume":"44","author":"Donaldson","year":"2006","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.mam.2013.10.004_b0195","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jhep.2010.05.033","article-title":"Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury","volume":"53","author":"Donaldson","year":"2010","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.mam.2013.10.004_b0200","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/gut.21.8.650","article-title":"Possible role of a defect in hepatic bilirubin glucuronidation in the initiation of cholesterol gallstones","volume":"21","author":"Duvaldestin","year":"1980","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0205","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/hep.25977","article-title":"Genome-wide association analysis in Primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4","volume":"58","author":"Ellinghaus","year":"2013","journal-title":"Hepatology"},{"issue":"Suppl","key":"10.1016\/j.mam.2013.10.004_b0210","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1194\/jlr.R800089-JLR200","article-title":"Nonalcoholic fatty liver disease","volume":"50","author":"Erickson","year":"2009","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/j.mam.2013.10.004_b0215","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1478-3231.2011.02534.x","article-title":"PNPLA3 rs738409C\/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence","volume":"31","author":"Falleti","year":"2011","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0220","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2005.02.042","article-title":"Prevalence of and risk factors for fatty liver in a general population of Shanghai","volume":"43","author":"Fan","year":"2005","journal-title":"China J. Hepatol."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0225","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1746.2005.03532.x","article-title":"Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese","volume":"20","author":"Fan","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0230","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2012.03.031","article-title":"Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci","volume":"57","author":"Folseraas","year":"2012","journal-title":"J. Hepatol."},{"issue":"7262","key":"10.1016\/j.mam.2013.10.004_b0235","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0240","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jhep.2012.04.017","article-title":"Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2","volume":"57","author":"Gonzales","year":"2012","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0245","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/hep.21847","article-title":"Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol","volume":"46","author":"Gr\u00fcnhage","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0250","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/gene.2009.60","article-title":"Receptor systems controlling natural killer cell function are genetically stratified in Europe","volume":"11","author":"Guinan","year":"2010","journal-title":"Genes Immun."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0255","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhep.2012.09.036","article-title":"PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis","volume":"58","author":"Guyot","year":"2013","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.mam.2013.10.004_b0260","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1194\/jlr.M300522-JLR200","article-title":"Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity","volume":"45","author":"Gylling","year":"2004","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0265","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","article-title":"Bile acid transporters and regulatory nuclear receptors in the liver and beyond","volume":"58","author":"Halilbasic","year":"2013","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.mam.2013.10.004_b0270","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0025-6196(12)60897-0","article-title":"Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis","volume":"68","author":"Hashimoto","year":"1993","journal-title":"Mayo Clin. Proc."},{"issue":"9","key":"10.1016\/j.mam.2013.10.004_b0275","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1074\/jbc.M109.064501","article-title":"A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis","volume":"285","author":"He","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.mam.2013.10.004_b0280","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ng.631","article-title":"Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis","volume":"42","author":"Hirschfield","year":"2010","journal-title":"Nat. Genet."},{"issue":"24","key":"10.1016\/j.mam.2013.10.004_b0285","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0290","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/FPC.0b013e32835e95e1","article-title":"The NAT2 tag SNP rs1495741 correlates with the susceptibility of antituberculosis drug-induced hepatotoxicity","volume":"23","author":"Ho","year":"2013","journal-title":"Pharmacogenet. Genomics"},{"issue":"8","key":"10.1016\/j.mam.2013.10.004_b0295","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1074\/jbc.M305782200","article-title":"Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition","volume":"279","author":"Ho","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mam.2013.10.004_b0300","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1471-2350-11-172","article-title":"Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease","volume":"11","author":"Hotta","year":"2010","journal-title":"BMC Med. Genet."},{"issue":"8","key":"10.1016\/j.mam.2013.10.004_b0305","doi-asserted-by":"crossref","first-page":"e12403","DOI":"10.1371\/journal.pone.0012403","article-title":"Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis","volume":"5","author":"Hov","year":"2010","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.mam.2013.10.004_b0310","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jhep.2009.11.029","article-title":"Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C","volume":"52","author":"Hov","year":"2010","journal-title":"J. Hepatol."},{"issue":"43","key":"10.1016\/j.mam.2013.10.004_b0315","doi-asserted-by":"crossref","first-page":"37085","DOI":"10.1074\/jbc.M111.290114","article-title":"Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease","volume":"286","author":"Huang","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.mam.2013.10.004_b0320","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1073\/pnas.1003585107","article-title":"A feed-forward loop amplifies nutritional regulation of PNPLA3","volume":"107","author":"Huang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0325","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/jhep.2002.32102","article-title":"Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis","volume":"35","author":"Huang","year":"2002","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.mam.2013.10.004_b0330","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/CS20100246","article-title":"A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease","volume":"120","author":"Iwata","year":"2011","journal-title":"Clin. Sci. (London)"},{"issue":"11","key":"10.1016\/j.mam.2013.10.004_b0335","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2893.2010.01363.x","article-title":"The role of bile acid retention and a common polymorphism in the ABCB11 gene as host factors affecting antiviral treatment response in chronic hepatitis C","volume":"18","author":"Iwata","year":"2011","journal-title":"J. Viral Hepat."},{"issue":"Suppl. 1","key":"10.1016\/j.mam.2013.10.004_b0340","doi-asserted-by":"crossref","first-page":"S542","DOI":"10.1016\/S0168-8278(11)61371-8","article-title":"Telaprevir substantially improved SVR rates across all IL28B genotypes in the ADVANCE trial","volume":"54","author":"Jacobson","year":"2011","journal-title":"J. Hepatol."},{"issue":"47","key":"10.1016\/j.mam.2013.10.004_b0345","doi-asserted-by":"crossref","first-page":"48968","DOI":"10.1074\/jbc.M407841200","article-title":"Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities","volume":"279","author":"Jenkins","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0350","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1194\/jlr.M700295-JLR200","article-title":"Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients","volume":"49","author":"Jiang","year":"2008","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0355","first-page":"870","article-title":"One more piece in the interleukin 28B gene puzzle?","volume":"57","author":"Jilg","year":"2013","journal-title":"Case Hepatitis B. Hepatol."},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0360","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1089-3261(03)00095-3","article-title":"Genetic factors in the pathogenesis of primary biliary cirrhosis","volume":"7","author":"Jones","year":"2003","journal-title":"Clin. Liver Dis."},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0365","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1440-1746.2005.03725.x","article-title":"Usefulness of combined measurement of serum bile acids and ferritin as additional prognostic markers to predict failure to reach sustained response to antiviral treatment in chronic hepatitis C","volume":"20","author":"Jorquera","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.mam.2013.10.004_b0370","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/ajg.2009.103","article-title":"Common genetic variation and haplotypes of the anion exchanger SLC4A2 in primary biliary cirrhosis","volume":"104","author":"Juran","year":"2009","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0375","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1053\/j.gastro.2008.06.077","article-title":"Primary biliary cirrhosis is associated with a genetic variant in the 3\u2019 flanking region of the CTLA4 gene","volume":"135","author":"Juran","year":"2008","journal-title":"Gastroenterology"},{"issue":"23","key":"10.1016\/j.mam.2013.10.004_b0380","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1093\/hmg\/dds359","article-title":"Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants","volume":"21","author":"Juran","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0385","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cld.2008.02.007","article-title":"Genetics and genomics of primary biliary cirrhosis","volume":"12","author":"Juran","year":"2008","journal-title":"Clin. Liver Dis."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0390","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaut.2010.06.005","article-title":"Update on the genetics and genomics of PBC","volume":"35","author":"Juran","year":"2010","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0395","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0031-1276641","article-title":"Genomics in the post-GWAS era","volume":"31","author":"Juran","year":"2011","journal-title":"Semin. Liver Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.mam.2013.10.004_b0400","first-page":"1199A","article-title":"Exome sequencing in a PSC family identifies a nonsense mutation in the biliary transporter ABCB4","volume":"54","author":"Juran","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.mam.2013.10.004_b0405","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/ng.348","article-title":"A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians","volume":"41","author":"Kamatani","year":"2009","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0410","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0415","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1053\/j.gastro.2006.05.057","article-title":"Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis","volume":"131","author":"Karlsen","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.mam.2013.10.004_b0420","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.20654","article-title":"Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs","volume":"41","author":"Katsika","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0425","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2796.2010.02249.x","article-title":"Gallstone disease in Swedish twins: risk is associated with ABCG8 D19H genotype","volume":"268","author":"Katsika","year":"2010","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0430","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jhep.2010.07.032","article-title":"Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b","volume":"54","author":"Kawaoka","year":"2011","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0435","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/hep.23032","article-title":"The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders","volume":"50","author":"Keitel","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0440","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbrc.2008.04.171","article-title":"Expression and function of the bile acid receptor TGR5 in Kupffer cells","volume":"372","author":"Keitel","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Suppl","key":"10.1016\/j.mam.2013.10.004_b0445","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1194\/jlr.R800082-JLR200","article-title":"Mammalian patatin domain containing proteins: a family with diverse lipolytic activities involved in multiple biological functions","volume":"50","author":"Kienesberger","year":"2009","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0450","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/sj.tpj.6500458","article-title":"Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis","volume":"8","author":"Kindmark","year":"2008","journal-title":"Pharmacogenomics J."},{"issue":"5","key":"10.1016\/j.mam.2013.10.004_b0455","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jhep.2013.02.002","article-title":"IL28B testing in a rapidly changing world: still relevant?","volume":"58","author":"King","year":"2013","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.mam.2013.10.004_b0460","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s00125-009-1285-z","article-title":"A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans","volume":"52","author":"Kotronen","year":"2009","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0465","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jhep.2007.07.027","article-title":"Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans","volume":"48","author":"Kovacs","year":"2008","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0470","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jhep.2010.10.042","article-title":"Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease","volume":"55","author":"Krawczyk","year":"2011","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.mam.2013.10.004_b0475","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/hep.25563","article-title":"Phytosterol and cholesterol precursor levels indicate increased cholesterol excretion and biosynthesis in gallstone disease","volume":"55","author":"Krawczyk","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0480","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clinre.2012.09.002","article-title":"Genetics of biliary lithiasis from an ethnic perspective","volume":"37","author":"Krawczyk","year":"2013","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"12","key":"10.1016\/j.mam.2013.10.004_b0485","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrgastro.2010.170","article-title":"Genome-wide association studies and genetic risk assessment of liver diseases","volume":"7","author":"Krawczyk","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0490","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000324140","article-title":"Genetic variants of the bile salt export pump: inducers and modifiers of liver diseases","volume":"29","author":"Kubitz","year":"2011","journal-title":"Dig. Dis."},{"issue":"5","key":"10.1016\/j.mam.2013.10.004_b0495","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.809","article-title":"Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma","volume":"43","author":"Kumar","year":"2011","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.mam.2013.10.004_b0500","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cmet.2012.04.008","article-title":"Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase","volume":"15","author":"Kumari","year":"2012","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.mam.2013.10.004_b0505","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.dld.2011.05.009","article-title":"Immune-mediated diseases in primary sclerosing cholangitis","volume":"43","author":"Lamberts","year":"2011","journal-title":"Dig. Liver Dis."},{"issue":"Suppl 1","key":"10.1016\/j.mam.2013.10.004_b0510","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.jhep.2008.01.012","article-title":"Gallstone disease: from genes to evidence-based therapy","volume":"48","author":"Lammert","year":"2008","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0515","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/hep.25749","article-title":"IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B","volume":"57","author":"Lampertico","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0520","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jhep.2005.03.012","article-title":"Pediatric gallstone disease in familial hypobetalipoproteinemia","volume":"43","author":"Lancellotti","year":"2005","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0525","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.fpc.0000230418.28091.76","article-title":"Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury","volume":"17","author":"Lang","year":"2007","journal-title":"Pharmacogenet. Genomics"},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0530","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jhep.2013.04.032","article-title":"Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma","volume":"59","author":"Lange","year":"2013","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0535","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jhep.2013.02.009","article-title":"A Phase 2a Trial of 12-Week Interferon-Free Therapy with Two Direct-Acting Antivirals (ABT-450\/r, ABT-072) and Ribavirin in IL28B C\/C Patients with Chronic Hepatitis C Genotype 1","volume":"59","author":"Lawitz","year":"2013","journal-title":"J Hepatol."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0540","doi-asserted-by":"crossref","first-page":"e58071","DOI":"10.1371\/journal.pone.0058071","article-title":"IL28B Polymorphism Correlates with Active Hepatitis in Patients with HBeAg-Negative Chronic Hepatitis B","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0545","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nm.3104","article-title":"Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy","volume":"19","author":"Li","year":"2013","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.mam.2013.10.004_b0550","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1172\/JCI65179","article-title":"Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis","volume":"122","author":"Li","year":"2012","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0555","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.ppat.0040002","article-title":"Role of ABO secretor status in mucosal innate immunity and H. pylori infection","volume":"4","author":"Linden","year":"2008","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.mam.2013.10.004_b0560","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/ng.2395","article-title":"Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis","volume":"44","author":"Liu","year":"2012","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.mam.2013.10.004_b0565","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng.2616","article-title":"Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis","volume":"45","author":"Liu","year":"2013","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0570","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/0003-4819-156-4-201202210-00005","article-title":"New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis","volume":"156","author":"Liu","year":"2012","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.mam.2013.10.004_b0575","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ng.627","article-title":"Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis","volume":"42","author":"Liu","year":"2010","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0580","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22736","article-title":"Apotopes and the biliary specificity of primary biliary cirrhosis","volume":"49","author":"Lleo","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.mam.2013.10.004_b0585","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1053\/gast.1996.v110.pm8613055","article-title":"Primary sclerosing cholangitis is associated with nonsmoking: a case-control study","volume":"110","author":"Loftus","year":"1996","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0590","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","article-title":"Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles","volume":"141","author":"Lucena","year":"2011","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.mam.2013.10.004_b0595","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1053\/j.gastro.2006.10.024","article-title":"Cholesterol gallstone susceptibility loci: a mouse map, candidate gene evaluation, and guide to human LITH genes","volume":"131","author":"Lyons","year":"2006","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0600","doi-asserted-by":"crossref","first-page":"e821","DOI":"10.1053\/j.gastro.2010.05.079","article-title":"An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response","volume":"139","author":"Mangia","year":"2010","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.mam.2013.10.004_b0605","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1053\/j.gastro.2010.02.009","article-title":"Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin","volume":"138","author":"McCarthy","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0610","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.21214","article-title":"Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver","volume":"44","author":"Meier","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0615","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3748\/wjg.14.38","article-title":"Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump","volume":"14","author":"Meier","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0620","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.789","article-title":"Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis","volume":"43","author":"Mells","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mam.2013.10.004_b0625","first-page":"265A","article-title":"Variation in the MDR3 gene influences disease progression in PSC patients and disease susceptibility in epistatic interaction with polymorphism in OST-alpha gene","volume":"46","author":"Melum","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0630","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.728","article-title":"Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci","volume":"43","author":"Melum","year":"2011","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0635","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hep.21964","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms","volume":"47","author":"Melum","year":"2008","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.mam.2013.10.004_b0640","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ng.876","article-title":"Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers","volume":"43","author":"Miki","year":"2011","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0645","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gut.51.4.567","article-title":"Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study","volume":"51","author":"Mitchell","year":"2002","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0650","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.26077","article-title":"Human leukocyte antigen (HLA)-B\u221757:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury","volume":"57","author":"Monshi","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0655","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hep.23624","article-title":"Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes","volume":"52","author":"Montes-Cano","year":"2010","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.mam.2013.10.004_b0660","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/nm1138","article-title":"Prevention of cholesterol gallstone disease by FXR agonists in a mouse model","volume":"10","author":"Moschetta","year":"2004","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0665","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1399-0039.2005.00351.x","article-title":"Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis","volume":"65","author":"Mullarkey","year":"2005","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.mam.2013.10.004_b0670","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-230X-12-63","article-title":"A frequent variant in the human bile salt export pump gene ABCB11 is associated with hepatitis C virus infection, but not liver stiffness in a German population","volume":"12","author":"M\u00fcllenbach","year":"2012","journal-title":"BMC Gastroenterol."},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0675","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.clinre.2012.02.003","article-title":"Genetics in primary sclerosing cholangitis","volume":"36","author":"Naess","year":"2012","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0680","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ajhg.2012.08.010","article-title":"Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population","volume":"91","author":"Nakamura","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.mam.2013.10.004_b0685","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1478-3231.2008.01914.x","article-title":"ABCB4 sequence variations in young adults with cholesterol gallstone disease","volume":"29","author":"Nakken","year":"2009","journal-title":"Liver Int."},{"issue":"11","key":"10.1016\/j.mam.2013.10.004_b0690","doi-asserted-by":"crossref","first-page":"e27087","DOI":"10.1371\/journal.pone.0027087","article-title":"The PNPLA3 rs738409 148M\/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis","volume":"6","author":"Nischalke","year":"2011","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.mam.2013.10.004_b0695","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ng.792","article-title":"Common variation in GPC5 is associated with acquired nephrotic syndrome","volume":"43","author":"Okamoto","year":"2011","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.mam.2013.10.004_b0700","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0168-8278(05)80617-8","article-title":"DNA typing of HLA class II genes; DRB1\u22170803 increases the susceptibility of Japanese to primary biliary cirrhosis","volume":"21","author":"Onishi","year":"1994","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.mam.2013.10.004_b0705","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/00498254.2011.555567","article-title":"Genetic polymorphisms in Na+-taurocholate co-transporting polypeptide (NTCP) and ileal apical sodium-dependent bile acid transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populations","volume":"41","author":"Pan","year":"2011","journal-title":"Xenobiotica"},{"issue":"Suppl. 1","key":"10.1016\/j.mam.2013.10.004_b0710","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0168-8278(11)60014-7","article-title":"IL28B polymorphism predicts virological response in patients with hepatitis C genotype 1 treated with boceprevir combination therapy","volume":"54","author":"Poodard","year":"2011","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0715","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1053\/j.gastro.2012.05.011","article-title":"Factors that predict response of patients with hepatitis C virus infection to boceprevir","volume":"143","author":"Poordad","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.mam.2013.10.004_b0720","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2008.07.027","article-title":"Genetic factors of susceptibility and of severity in primary biliary cirrhosis","volume":"49","author":"Poupon","year":"2008","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0725","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0016-5085(93)90735-U","article-title":"Abnormal expression of anion exchanger genes in primary biliary cirrhosis","volume":"105","author":"Prieto","year":"1993","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0730","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.mam.2013.10.004_b0735","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0016-5085(83)80085-7","article-title":"Familial occurrence of primary sclerosing cholangitis and ulcerative colitis","volume":"85","author":"Quigley","year":"1983","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.mam.2013.10.004_b0740","doi-asserted-by":"crossref","first-page":"F23","DOI":"10.1097\/QAD.0b013e3283391d6d","article-title":"Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV\/hepatitis C virus-coinfected patients","volume":"24","author":"Rallon","year":"2010","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0745","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.mam.2013.10.004_b0750","doi-asserted-by":"crossref","first-page":"e7321","DOI":"10.1371\/journal.pone.0007321","article-title":"A variant of the SLC10A2 gene encoding the apical sodium-dependent bile acid transporter is a risk factor for gallstone disease","volume":"4","author":"Renner","year":"2009","journal-title":"PLoS ONE"},{"issue":"133","key":"10.1016\/j.mam.2013.10.004_b0755","first-page":"133ra158","article-title":"The predictive capacity of personal genome sequencing","volume":"4","author":"Roberts","year":"2012"},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0760","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MOL.0b013e328338ca61","article-title":"Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein","volume":"21","author":"Romeo","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"issue":"12","key":"10.1016\/j.mam.2013.10.004_b0765","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0770","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2010.02.034","article-title":"The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life","volume":"53","author":"Romeo","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2013.10.004_b0775","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1172-2-29","article-title":"Low phospholipid associated cholelithiasis: association with mutation in the MDR3\/ABCB4 gene","volume":"2","author":"Rosmorduc","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0780","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/hep.23759","article-title":"The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease","volume":"52","author":"Rotman","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0785","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/hep.23720","article-title":"Pharmacogenetics of drug-induced liver injury","volume":"52","author":"Russmann","year":"2010","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.mam.2013.10.004_b0790","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1111\/j.1572-0241.2000.03292.x","article-title":"Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis","volume":"95","author":"Saarinen","year":"2000","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.mam.2013.10.004_b0795","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1053\/j.gastro.2008.02.020","article-title":"Ae2a, b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis","volume":"134","author":"Salas","year":"2008","journal-title":"Gastroenterology"},{"issue":"19","key":"10.1016\/j.mam.2013.10.004_b0800","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1073\/pnas.0707882105","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C","volume":"105","author":"Sarasin-Filipowicz","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl. 1","key":"10.1016\/j.mam.2013.10.004_b0805","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/S0168-8278(12)60010-5","article-title":"Antiviral strategies in hepatitis C virus infection","volume":"56","author":"Sarrazin","year":"2012","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0810","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2010.07.041","article-title":"Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients","volume":"54","author":"Sarrazin","year":"2010","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.mam.2013.10.004_b0815","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jhep.2010.08.024","article-title":"Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin","volume":"54","author":"Scherzer","year":"2011","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0820","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jhep.2007.09.015","article-title":"Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR","volume":"48","author":"Scholtes","year":"2008","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0825","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.mam.2013.10.004_b0830","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ng.632","article-title":"A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury","volume":"42","author":"Singer","year":"2010","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0835","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.gastro.2011.11.025","article-title":"Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B","volume":"142","author":"Sonneveld","year":"2012","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.mam.2013.10.004_b0840","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1194\/jlr.P900013-JLR200","article-title":"A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity","volume":"50","author":"Sookoian","year":"2009","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.mam.2013.10.004_b0845","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.24283","article-title":"Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease","volume":"53","author":"Sookoian","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0850","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/hep.23768","article-title":"PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease","volume":"52","author":"Speliotes","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0855","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/hep.24046","article-title":"Sterol transporter adenosine triphosphate-binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population","volume":"53","author":"Stender","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0860","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/hep.24017","article-title":"Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians","volume":"53","author":"Stickel","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0865","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0016-5085(00)70224-1","article-title":"Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver","volume":"118","author":"Stieger","year":"2000","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b0870","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000323885","article-title":"Gallstones: environment, lifestyle and genes","volume":"29","author":"Stokes","year":"2011","journal-title":"Dig. Dis."},{"issue":"10","key":"10.1016\/j.mam.2013.10.004_b0875","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0880","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury","volume":"54","author":"Suzuki","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.mam.2013.10.004_b0885","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jhep.2009.01.015","article-title":"Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations","volume":"50","author":"Tanaka","year":"2009","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.mam.2013.10.004_b0890","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat. Genet."},{"issue":"7265","key":"10.1016\/j.mam.2013.10.004_b0895","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0900","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2010.04.013","article-title":"Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus","volume":"139","author":"Thompson","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2013.10.004_b0905","doi-asserted-by":"crossref","DOI":"10.1002\/hep.23826","article-title":"Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype","author":"Thompson","year":"2010","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.mam.2013.10.004_b0910","doi-asserted-by":"crossref","first-page":"15351","DOI":"10.1128\/JVI.79.24.15351-15355.2005","article-title":"A homozygous nonsense mutation (428G\u2192A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections","volume":"79","author":"Thorven","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0915","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng.488","article-title":"Variant in PNPLA3 is associated with alcoholic liver disease","volume":"42","author":"Tian","year":"2010","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.mam.2013.10.004_b0920","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1053\/j.gastro.2010.07.005","article-title":"A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice","volume":"139","author":"Tillmann","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2013.10.004_b0925","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1471-2350-12-149","article-title":"Effects of SLC10A2 variant rs9514089 on gallstone risk and serum cholesterol levels- meta-analysis of three independent cohorts","volume":"12","author":"T\u00f6njes","year":"2011","journal-title":"BMC Med. Genet."},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0930","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2006-960172","article-title":"MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes","volume":"27","author":"Trauner","year":"2007","journal-title":"Semin. Liver Dis."},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0935","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jhep.2011.01.028","article-title":"Common polymorphism in the PNPLA3\/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease","volume":"55","author":"Trepo","year":"2011","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0940","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/hep.25518","article-title":"PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis","volume":"55","author":"Trepo","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0945","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/hep.24350","article-title":"Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C","volume":"54","author":"Trepo","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0950","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/gtmb.2008.0095","article-title":"Gilbert syndrome as a predisposing factor for cholelithiasis risk in the Greek adult population","volume":"13","author":"Tsezou","year":"2009","journal-title":"Genet Test Mol Biomarkers"},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0955","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/hep.22175","article-title":"Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization","volume":"47","author":"Uppal","year":"2008","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.mam.2013.10.004_b0960","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/FPC.0b013e3283589a76","article-title":"Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs","volume":"22","author":"Urban","year":"2012","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.mam.2013.10.004_b0965","doi-asserted-by":"crossref","DOI":"10.1002\/hep.23912","article-title":"IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C","author":"Urban","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0970","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/hep.23622","article-title":"Homozygosity for the patatin-like phospholipase-3\/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"51","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b0975","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/hep.23823","article-title":"I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease","volume":"52","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0980","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.24123","article-title":"Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C","volume":"53","author":"Valenti","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0985","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/hep.23268","article-title":"Folding defects in P-type ATP 8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate","volume":"51","author":"van der Velden","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b0990","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/BJ20060537","article-title":"Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation","volume":"398","author":"Vassileva","year":"2006","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b0995","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/jhep.2002.30084","article-title":"Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis","volume":"35","author":"Vogel","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b1000","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.20784","article-title":"CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice","volume":"42","author":"Wagner","year":"2005","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b1005","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/art.24412","article-title":"CTLA4\/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population","volume":"60","author":"Walker","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b1010","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/hep.20150","article-title":"From genotypes to haplotypes in hepatobiliary diseases: one plus one equals (sometimes) more than two","volume":"39","author":"Wasmuth","year":"2004","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b1015","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2011.02.024","article-title":"Drug induced liver injury and its relationship to autoimmune hepatitis","volume":"55","author":"Weiler-Normann","year":"2011","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.mam.2013.10.004_b1020","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1194\/jlr.M600185-JLR200","article-title":"Characterization of the human patatin-like phospholipase family","volume":"47","author":"Wilson","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mam.2013.10.004_b1025","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.mam.2013.10.004_b1030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.23976","article-title":"Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients","volume":"53","author":"Yu","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mam.2013.10.004_b1035","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ajhg.2008.09.012","article-title":"Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes","volume":"83","author":"Yuan","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"Suppl. 1","key":"10.1016\/j.mam.2013.10.004_b1040","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0168-8278(12)60024-5","article-title":"Peg-interferon lambda 1a (lambda) compared to peg-interferon alfa-2a (alfa) in treatment-naive patients with HCV genotypes (G) 2 or 3: first SVR24 results from EMERGE phase IIb","volume":"56","author":"Zeuzem","year":"2012","journal-title":"J. Hepatol."},{"issue":"Suppl. 1","key":"10.1016\/j.mam.2013.10.004_b1045","first-page":"308A","article-title":"Interferon (IFN)-free combination treatment with the HCV NS3\/4A protease inhibitor BI 201335 and the non-nucleoside NS5B inhibitor BI 207127 +\/- ribavirin (R): Final results of SOUND-C2 and predictors of response","volume":"56","author":"Zeuzem","year":"2012","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.mam.2013.10.004_b1050","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ng.638","article-title":"Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers","volume":"42","author":"Zhang","year":"2010","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b1055","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/hep.23041","article-title":"Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity","volume":"50","author":"Zhong","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mam.2013.10.004_b1060","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bpg.2011.02.007","article-title":"Genetics and epigenetics in the fibrogenic evolution of chronic liver diseases","volume":"25","author":"Zimmer","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"3","key":"10.1016\/j.mam.2013.10.004_b1065","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/MOG.0b013e3283444862","article-title":"Genetics in liver disease: new concepts","volume":"27","author":"Zimmer","year":"2011","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"8","key":"10.1016\/j.mam.2013.10.004_b1070","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1478-3231.2009.02026.x","article-title":"Combined functional variants of hepatobiliary transporters and FXR aggravate intrahepatic cholestasis of pregnancy","volume":"29","author":"Zimmer","year":"2009","journal-title":"Liver Int."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299713000800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299713000800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T20:41:42Z","timestamp":1596746502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299713000800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":214,"alternative-id":["S0098299713000800"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2013.10.004","relation":{},"ISSN":["0098-2997"],"issn-type":[{"type":"print","value":"0098-2997"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of genetics in diagnosis and therapy of acquired liver disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2013.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}